REFERENCES
- Costea N, Schwartz R, Constantoulakis M, et al: The use of radioactive antiglobulin for the detection of erythrocyte sensitization. Blood 20:214, 1962
- Gilliland BC, Baxter E, Evans RS: Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med 285:252, 1971
- Rosse WF: Fixation of the first component of complement (C'1a) by human antibodies. J Clin Invest 47:2430, 1968
- Luthringer DG, Jenkins DE Jr, Wallis LA: Autoimmune hemolytic anemia with hemo- globineniia and hemoglobinuria in the absence of demonstrable hemolysis or complement-binding antibody. Vox Sang 16:18, 1969
- Abramson N, Gelfand EW, Jandl JH, et al: The interaction between human monocytes and red cells: Binding characteristics. J Exp Med 132:1191, 1970
- Zuelzer WW, Mastrangelo R, Stulberg CS, et al: Autoimmune hemolytic anemia: Natural history and viral-immunologic interactions in childhood. Am J Med 49:80, 1970
- Strumia PV, Raymond FD: Acquired hemolytic anemia and antipenicillin antibody: Case report and review of the literature. Arch Intern Med 109:603, 1962
- LoBuglio AF, Jandl JH: The nature of alpha- methyldopa red-cell antibody. N Engl J Med 276:658, 1967
- Henry RE, Goldberg LS, Sturgeon P, et al: Serologic abnormalities associated with L-dopa therapy. Vox Sang 20:306, 1971
- Schwartz RS, Costea N: Autoimmune hemolytic anemia: Clinical correlations and biological implications. Semin Hematol 3:2, 1966
- Costea N, Yakulis V, Heller P: Light-chain heterogeneity of cold agglutinins. Science 152:1520, 1966
- Ruddy S, Austen KF: C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol 107:742, 1971.